Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Monash IVF Group Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Monash IVF Group kazanç ve gelirin sırasıyla yıllık 50.1% ve 6.4% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 50% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 13.6% olacağı tahmin edilmektedir.

Anahtar bilgiler

50.1%

Kazanç büyüme oranı

50.0%

EPS büyüme oranı

Healthcare kazanç büyümesi	26.2%
Gelir büyüme oranı	6.4%
Gelecekteki özkaynak getirisi	13.6%
Analist kapsamı	Good
Son güncelleme	22 Sep 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Shareholders Will Probably Not Have Any Issues With Monash IVF Group Limited's (ASX:MVF) CEO Compensation

Nov 04

Monash IVF Group's (ASX:MVF) Upcoming Dividend Will Be Larger Than Last Year's

Aug 29

Be Wary Of Monash IVF Group (ASX:MVF) And Its Returns On Capital

May 14

Should You Think About Buying Monash IVF Group Limited (ASX:MVF) Now?

Jun 06

Monash IVF Group (ASX:MVF) May Have Issues Allocating Its Capital

May 25

Is Monash IVF Group Limited (ASX:MVF) Expensive For A Reason? A Look At Its Intrinsic Value

May 13

Is Monash IVF Group Limited (ASX:MVF) A Smart Choice For Dividend Investors?

Mar 14

Just Four Days Till Monash IVF Group Limited (ASX:MVF) Will Be Trading Ex-Dividend

Mar 04

Monash IVF Group Limited (ASX:MVF) Just Released Its Half-Year Results And Analysts Are Updating Their Estimates

Feb 26

Is Now An Opportune Moment To Examine Monash IVF Group Limited (ASX:MVF)?

Feb 15

A Look At The Fair Value Of Monash IVF Group Limited (ASX:MVF)

Feb 03

We're Not So Sure You Should Rely on Monash IVF Group's (ASX:MVF) Statutory Earnings

Jan 22

Is Monash IVF Group Limited (ASX:MVF) Popular Amongst Institutions?

Jan 10

Is Monash IVF Group (ASX:MVF) Using Too Much Debt?

Dec 28

What Do The Returns On Capital At Monash IVF Group (ASX:MVF) Tell Us?

Dec 17

Monash IVF Group's (ASX:MVF) Shareholders Are Down 56% On Their Shares

Dec 06

Monash IVF Group Limited's (ASX:MVF) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?

Nov 24

Kazanç ve Gelir Büyüme Tahminleri

ASX:MVF - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (AUD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
6/30/2027	310	36	47	61	7
6/30/2026	294	34	44	58	8
6/30/2025	278	32	39	31	8
6/30/2024	255	-7	31	53	N/A
3/31/2024	246	9	27	51	N/A
12/31/2023	236	24	22	49	N/A
9/30/2023	225	23	17	44	N/A
6/30/2023	214	22	11	39	N/A
3/31/2023	204	19	11	36	N/A
12/31/2022	195	17	11	33	N/A
9/30/2022	193	18	16	32	N/A
6/30/2022	192	18	20	32	N/A
3/31/2022	193	21	25	35	N/A
12/31/2021	194	23	30	38	N/A
9/30/2021	189	24	32	41	N/A
6/30/2021	184	25	34	44	N/A
3/31/2021	171	22	33	43	N/A
12/31/2020	159	18	31	41	N/A
9/30/2020	152	15	27	36	N/A
6/30/2020	145	12	24	31	N/A
3/31/2020	149	15	22	30	N/A
12/31/2019	152	18	20	28	N/A
9/30/2019	152	19	23	31	N/A
6/30/2019	152	20	27	33	N/A
3/31/2019	151	19	25	31	N/A
12/31/2018	151	19	24	29	N/A
9/30/2018	151	20	22	28	N/A
6/30/2018	151	21	19	26	N/A
3/31/2018	152	24	N/A	N/A	N/A
12/31/2017	153	26	N/A	29	N/A
9/30/2017	154	28	N/A	28	N/A
6/30/2017	155	30	N/A	26	N/A
3/31/2017	156	30	N/A	N/A	N/A
12/31/2016	156	30	N/A	34	N/A
9/30/2016	156	29	N/A	39	N/A
6/30/2016	157	29	N/A	44	N/A
3/31/2016	150	27	N/A	41	N/A
12/31/2015	144	24	N/A	38	N/A
9/30/2015	134	23	N/A	37	N/A
6/30/2015	125	21	N/A	36	N/A
3/31/2015	121	15	N/A	37	N/A
12/31/2014	117	8	N/A	38	N/A
9/30/2014	115	5	N/A	37	N/A
6/30/2014	114	3	N/A	36	N/A
3/31/2014	110	2	N/A	37	N/A
12/31/2013	106	0	N/A	39	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: MVF önümüzdeki 3 yıl içerisinde kârlı hale gelmesi öngörülüyor; bu da tasarruf oranından ( 2.4% ) daha hızlı bir büyüme olarak değerlendiriliyor.

Kazançlar ve Piyasa: MVF önümüzdeki 3 yıl içerisinde karlı hale gelmesi öngörülüyor ki bu da ortalama piyasa büyümesinin üzerinde kabul ediliyor.

Yüksek Büyüme Kazançları: MVF önümüzdeki 3 yıl içinde karlı hale gelmesi bekleniyor.

Gelir ve Pazar: MVF şirketinin gelirinin (yıllık 6.4% ) Australian pazarından (yıllık 5.6% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: MVF şirketinin gelirinin (yıllık 6.4% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: MVF 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 13.6 %).

Monash IVF Group Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Price target increased by 7.3% to AU$1.42

Consensus forecasts updated

Consensus EPS estimates fall by 16%

Consensus EPS estimates fall by 10%

Monash IVF Group Limited Updates Temporary Suspension of IVF Procedures Lifted in Victoria

Price target increased to AU$1.08

Recent updates

Monash IVF Group Limited Announces Board Changes

Independent Non-Executive Director recently bought AU$93k worth of stock

Monash IVF Group's (ASX:MVF) Dividend Will Be A$0.025

Monash IVF Group Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on October 11, 2024

Full year 2024 earnings: EPS misses analyst expectations

Monash IVF Group Limited (ASX:MVF)completed the acquisition of 80% stake in Fertility North Holdings Pty Ltd.

Upcoming dividend of AU$0.025 per share

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.027 in 1H 2023)

Monash IVF Group's (ASX:MVF) Dividend Will Be A$0.025

First half dividend of AU$0.025 announced

Monash IVF Group Limited to Report First Half, 2024 Results on Feb 23, 2024

Price target increased by 7.3% to AU$1.42

Upcoming dividend of AU$0.022 per share at 3.5% yield

Monash IVF Group (ASX:MVF) Will Pay A Dividend Of A$0.022

Monash IVF Group Limited Announces Fully Franked Final Dividend for Fiscal Year Ended June 30, 2023, Payable on 11 October 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Monash IVF Group Limited Provides Update on Class Action Lawsuit

Monash IVF Group Limited (ASX:MVF) completed the acquisition of PIVET Medical Centre.

Upcoming dividend of AU$0.022 per share at 4.2% yield

First half 2023 earnings released: EPS: AU$0.027 (vs AU$0.031 in 1H 2022)

Monash IVF Group Limited to Report First Half, 2023 Results on Feb 21, 2023

Here's What's Concerning About Monash IVF Group's (ASX:MVF) Returns On Capital

Insufficient new directors

Shareholders Will Probably Not Have Any Issues With Monash IVF Group Limited's (ASX:MVF) CEO Compensation

Monash IVF Group Limited (ASX:MVF) completed the acquisition of ART Associates Queensland #2 Pty Ltd.

Consensus forecasts updated

Upcoming dividend of AU$0.022 per share

Monash IVF Group's (ASX:MVF) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2022 earnings: EPS misses analyst expectations

Monash IVF Group Limited Announces Ordinary Fully Paid Distribution for the Six Months Ended June 30, 2022, Payable on October 7, 2022

Monash IVF Group Limited to Report Fiscal Year 2022 Results on Aug 26, 2022

Monash IVF Group Limited, Annual General Meeting, Nov 11, 2022

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) agreed to acquire PIVET Medical Centre for AUD 9.4 million.

Consensus EPS estimates fall by 16%

Be Wary Of Monash IVF Group (ASX:MVF) And Its Returns On Capital

Consensus EPS estimates fall by 10%

Insufficient new directors

Monash IVF Group Limited Announces Fully Franked Distribution for the Six Months That Ended December 31, 2021, Payable on April 4, 2022

Monash IVF Group Limited to Report First Half, 2022 Results on Feb 17, 2022

Monash IVF Group Limited Updates Temporary Suspension of IVF Procedures Lifted in Victoria

Upcoming dividend of AU$0.021 per share

Full year 2021 earnings released: EPS AU$0.065 (vs AU$0.046 in FY 2020)

Price target increased to AU$1.08

Should You Think About Buying Monash IVF Group Limited (ASX:MVF) Now?

Monash IVF Group (ASX:MVF) May Have Issues Allocating Its Capital

Is Monash IVF Group Limited (ASX:MVF) Expensive For A Reason? A Look At Its Intrinsic Value

Independent Non-Executive Director recently bought AU$192k worth of stock

Is Monash IVF Group Limited (ASX:MVF) A Smart Choice For Dividend Investors?

Just Four Days Till Monash IVF Group Limited (ASX:MVF) Will Be Trading Ex-Dividend

Monash IVF Group Limited (ASX:MVF) Just Released Its Half-Year Results And Analysts Are Updating Their Estimates

Revenue and earnings beat expectations

First half 2021 earnings released: EPS AU$0.037 (vs AU$0.035 in 1H 2020)

New 90-day high: AU$0.80

Is Now An Opportune Moment To Examine Monash IVF Group Limited (ASX:MVF)?

A Look At The Fair Value Of Monash IVF Group Limited (ASX:MVF)

We're Not So Sure You Should Rely on Monash IVF Group's (ASX:MVF) Statutory Earnings

Is Monash IVF Group Limited (ASX:MVF) Popular Amongst Institutions?

Is Monash IVF Group (ASX:MVF) Using Too Much Debt?

What Do The Returns On Capital At Monash IVF Group (ASX:MVF) Tell Us?

Monash IVF Group's (ASX:MVF) Shareholders Are Down 56% On Their Shares

Price target raised to AU$0.88

Analysts increase EPS estimates to AU$0.06

Monash IVF Group Limited's (ASX:MVF) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?

New 90-day high: AU$0.71

Analysts increase EPS estimates to AU$0.053

Price target raised to AU$0.80